Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9BRI3: Variant p.Gly87Arg

Proton-coupled zinc antiporter SLC30A2
Gene: SLC30A2
Feedback?
Variant information Variant position: help 87 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Arginine (R) at position 87 (G87R, p.Gly87Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In TNZD; decreased zinc ion import into organelle; dominant negative effect; changed protein localization; retained in endoplasmic reticulum and Golgi; dominant negative effect; results in decreased zinc secretion in milk. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 87 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 372 The length of the canonical sequence.
Location on the sequence: help KGKAQRQLYVASAICLLFMI G EVVGGYLAHSLAVMTDAAHL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         KGKAQRQLYVASAICLLFMIGEVVGGYLAHSLAVMTDAAHL

Mouse                         KQRARRKLYVASAICLVFMIGEIIGGYLAQSLAIMTDAAHL

Rat                           KQRARRKLYVASAICLVFMIGEIIGGYLAQSLAIMTDAAHL
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 372 Proton-coupled zinc antiporter SLC30A2
Topological domain 1 – 140 Cytoplasmic
Binding site 106 – 106



Literature citations
Heterodimerization, altered subcellular localization, and function of multiple zinc transporters in viable cells using bimolecular fluorescence complementation.
Golan Y.; Berman B.; Assaraf Y.G.;
J. Biol. Chem. 290:9050-9063(2015)
Cited for: FUNCTION (ISOFORM 1); SUBUNIT; CHARACTERIZATION OF VARIANT TNZD ARG-87; A dominant negative heterozygous G87R mutation in the zinc transporter, ZnT-2 (SLC30A2), results in transient neonatal zinc deficiency.
Lasry I.; Seo Y.A.; Ityel H.; Shalva N.; Pode-Shakked B.; Glaser F.; Berman B.; Berezovsky I.; Goncearenco A.; Klar A.; Levy J.; Anikster Y.; Kelleher S.L.; Assaraf Y.G.;
J. Biol. Chem. 287:29348-29361(2012)
Cited for: VARIANT TNZD ARG-87; CHARACTERIZATION OF VARIANT TNZD ARG-87; FUNCTION (ISOFORM 1); SUBUNIT; MUTAGENESIS OF 134-PHE--GLU-140;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.